Our lab is interested in understanding epigenetic regulation of transcription in the mammalian genome that governs cell fate decisions during embryonic development and human diseases. We aim to develop novel therapeutic strategies for age-related disorders (i.e. cancer) as well as rare diseases (i.e. multiple familial cerebral cavernomatosis).